These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 34659216)
1. Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment. Xu Y; Zhang H; Sun Q; Geng R; Yuan F; Liu B; Chen Q Front Immunol; 2021; 12():730289. PubMed ID: 34659216 [TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes. Qi Y; Liu B; Sun Q; Xiong X; Chen Q Front Immunol; 2020; 11():578877. PubMed ID: 33329549 [TBL] [Abstract][Full Text] [Related]
3. A Systematic Review of the Tumor-Infiltrating CD8 Shadbad MA; Asadzadeh Z; Hosseinkhani N; Derakhshani A; Alizadeh N; Brunetti O; Silvestris N; Baradaran B Front Immunol; 2021; 12():734956. PubMed ID: 34603316 [TBL] [Abstract][Full Text] [Related]
4. Immune Checkpoint Inhibitors in Human Glioma Microenvironment. Ghouzlani A; Kandoussi S; Tall M; Reddy KP; Rafii S; Badou A Front Immunol; 2021; 12():679425. PubMed ID: 34305910 [TBL] [Abstract][Full Text] [Related]
5. Tryptophan metabolism in brain tumors - IDO and beyond. Platten M; Friedrich M; Wainwright DA; Panitz V; Opitz CA Curr Opin Immunol; 2021 Jun; 70():57-66. PubMed ID: 33813026 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for glioma: from illusion to realistic prospects? Dietrich PY; Dutoit V; Walker PR Am Soc Clin Oncol Educ Book; 2014; ():51-9. PubMed ID: 24857060 [TBL] [Abstract][Full Text] [Related]
7. Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma. Zhang S; Chen S; Wang Z; Li J; Yuan Y; Feng W; Li W; Chen M; Liu Y Front Pharmacol; 2022; 13():1061597. PubMed ID: 36386216 [TBL] [Abstract][Full Text] [Related]
8. Immune microenvironment of gliomas. Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634 [TBL] [Abstract][Full Text] [Related]
9. Shaping the glioma immune microenvironment through tryptophan metabolism. Platten M; Weller M; Wick W CNS Oncol; 2012 Sep; 1(1):99-106. PubMed ID: 25054303 [TBL] [Abstract][Full Text] [Related]
10. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors. Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124 [TBL] [Abstract][Full Text] [Related]
11. Tumor infiltrating immune cells in gliomas and meningiomas. Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710 [TBL] [Abstract][Full Text] [Related]
12. Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment. Levine AB; Nobre L; Das A; Milos S; Bianchi V; Johnson M; Fernandez NR; Stengs L; Ryall S; Ku M; Rana M; Laxer B; Sheth J; Sbergio SG; Fedoráková I; Ramaswamy V; Bennett J; Siddaway R; Tabori U; Hawkins C Nat Commun; 2024 Jul; 15(1):5790. PubMed ID: 38987542 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084 [TBL] [Abstract][Full Text] [Related]
14. Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme. Sokratous G; Polyzoidis S; Ashkan K Hum Vaccin Immunother; 2017 Nov; 13(11):2575-2582. PubMed ID: 28362548 [TBL] [Abstract][Full Text] [Related]
15. TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas. Chen R; Wang X; Dai Z; Wang Z; Wu W; Hu Z; Zhang X; Liu Z; Zhang H; Cheng Q Front Immunol; 2021; 12():713757. PubMed ID: 34712225 [TBL] [Abstract][Full Text] [Related]
16. Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. Ott M; Tomaszowski KH; Marisetty A; Kong LY; Wei J; Duna M; Blumberg K; Ji X; Jacobs C; Fuller GN; Langford LA; Huse JT; Long JP; Hu J; Li S; Weinberg JS; Prabhu SS; Sawaya R; Ferguson S; Rao G; Lang FF; Curran MA; Heimberger AB JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32721947 [TBL] [Abstract][Full Text] [Related]
17. Neutrophils in glioma microenvironment: from immune function to immunotherapy. Sun C; Wang S; Ma Z; Zhou J; Ding Z; Yuan G; Pan Y Front Immunol; 2024; 15():1393173. PubMed ID: 38779679 [TBL] [Abstract][Full Text] [Related]
18. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. Chirasani SR; Leukel P; Gottfried E; Hochrein J; Stadler K; Neumann B; Oefner PJ; Gronwald W; Bogdahn U; Hau P; Kreutz M; Grauer OM Int J Cancer; 2013 Feb; 132(4):843-53. PubMed ID: 22752934 [TBL] [Abstract][Full Text] [Related]
19. Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade. Dejaegher J; Verschuere T; Vercalsteren E; Boon L; Cremer J; Sciot R; Van Gool SW; De Vleeschouwer S Int J Cancer; 2017 Nov; 141(9):1891-1900. PubMed ID: 28681455 [TBL] [Abstract][Full Text] [Related]
20. Engineered Cell Membrane-Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation. Ma Y; Yi J; Ruan J; Ma J; Yang Q; Zhang K; Zhang M; Zeng G; Jin L; Huang X; Li J; Yang H; Wu W; Sun D Adv Healthc Mater; 2024 Aug; 13(20):e2400514. PubMed ID: 38652681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]